Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health News of Alabama.
Press releases published on April 7, 2025
Adaptin Bio, Inc., a Lucius Partners Portfolio Company, Completes Alternative Public Offering (APO) and Closes $7.7 Million Private Placement
GlobeNewswire
·
April 7, 2025
Funding expected to support first clinical trial of APTN-101 for the treatment of glioblastoma CHARLOTTE, N.C., April 07, 2025 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (“Adaptin” or the “Company”), a biotechnology company focused on developing precision …
BON Announces Breakthrough in the Bio-manufacturing Technology of Tea Pigments
GlobeNewswire
·
April 7, 2025
XI’AN, China, April 07, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced between October 2024 to January 2025, …
Mitolyn Reviews (April 2025 REPORT): The Metabolic Reset Formula Experts Are Rushing to Evaluate
GlobeNewswire
·
April 7, 2025
BOSTON, MA, April 07, 2025 (GLOBE NEWSWIRE) -- Mitolyn For years, weight loss supplements have promised quick fixes and overnight transformations, but most fail to deliver sustainable results. The real issue? They ignore the body’s core energy production …
Confluent Medical Technologies Announces Ultra Polyimide
GlobeNewswire
·
April 7, 2025
SCOTTSDALE, Ariz., April 07, 2025 (GLOBE NEWSWIRE) -- Confluent Medical Technologies (Confluent), a leading medical device and materials science contract manufacturer specializing in polymer and metal components, has announced the launch of Ultra Polyimide …
AquaSculpt Review (APRIL CONSUMER UPDATE): Why Everyone’s Talking About This Fat-Freezing Weight Loss Shortcut
GlobeNewswire
·
April 7, 2025
BOSTON, MA, April 07, 2025 (GLOBE NEWSWIRE) -- AQUASCULPT The weight loss industry is flooded with fads, gimmicks, and overhyped miracle cures that promise dramatic transformations yet fail to deliver. But AquaSculpt reviews are taking the internet by …
Benevis Thanks Its Team of 250 Plus Dental Hygienists for Their Essential Role in Helping Underserved Patients Across the Nation Protect Their Oral Health
GlobeNewswire
·
April 7, 2025
Atlanta, GA, April 07, 2025 (GLOBE NEWSWIRE) -- Benevis and its 100-plus locally branded dental practices have come together in recognition of Dental Hygienist Week from April 7 through 12, 2025. As a leading dental healthcare and orthodontics delivery …
The BRAVE Trauma Therapist Collective Launches Second Annual Reach 100 Drive to Strengthen Trauma Therapist Community
GlobeNewswire
·
April 7, 2025
HOUSTON, April 07, 2025 (GLOBE NEWSWIRE) -- The BRAVE Trauma Therapist Collective today announced the launch of its Second Annual Reach 100 Drive, a community-powered membership and fundraising initiative designed to expand access to support for trauma …
Conversations Today to Empower Tomorrow: VITAS® Healthcare Elevates National Healthcare Decisions Day
GlobeNewswire
·
April 7, 2025
MIAMI, April 07, 2025 (GLOBE NEWSWIRE) -- Only one in three adults in the United States have a written advance directive, a document critical in providing guidance to medical teams regarding one’s end-of-life wishes. As a pioneer and national leader in …
Prime Biome Reviews (SHOCKING RESEARCH EXPOSED): Does This Gut-Skin Link Actually Hold Up in 2025?
GlobeNewswire
·
April 7, 2025
SEATTLE, WA, April 07, 2025 (GLOBE NEWSWIRE) -- PRIME BIOME In a world obsessed with gut health and skincare, Prime Biome has rapidly become one of the most talked-about supplements of 2025. Touted as a gut-skin breakthrough, this probiotic formula claims …
Nelipak® Healthcare Packaging Expands Commitment to Serve Customers in Asia-Pacific Region with its Sterile Barrier Medical Packaging Products
GlobeNewswire
·
April 7, 2025
CRANSTON, R.I., April 07, 2025 (GLOBE NEWSWIRE) -- Nelipak® Corporation (“Nelipak®”), a leading global manufacturer of packaging solutions for medical device, diagnostic, pharmaceutical drug delivery, and other demanding applications, announced it is …
Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology
GlobeNewswire
·
April 7, 2025
Key structural and mechanistic insights into BSEP transporter mutations that lead to improper protein folding and function Findings have potentially broad-ranging clinical relevance for multiple hepatobiliary diseases including progressive familial …
Surplus Solutions, an NMS Capital Portfolio Company, Expands Capabilities in Refurbished Laboratory Equipment and Technical Services; Announces Partnership with Certified Genetool
GlobeNewswire
·
April 7, 2025
NEW YORK and WOONSOCKET, R.I., April 07, 2025 (GLOBE NEWSWIRE) -- Surplus Solutions LLC (“Surplus Solutions”), a portfolio company of NMS Capital (“NMS”), announced today the acquisition of Certified Genetool (or the “Company”), a San Francisco-based …
Sharecare Names Industry Veteran Elizabeth Delahoussaye as Chief Privacy Officer of Health Data Solutions
GlobeNewswire
·
April 7, 2025
ATLANTA , April 07, 2025 (GLOBE NEWSWIRE) -- Sharecare, the health tech company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced that seasoned healthcare compliance and privacy …
ImmuCell Hires Chief Financial Officer
GlobeNewswire
·
April 7, 2025
PORTLAND, Maine, April 07, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies
GlobeNewswire
·
April 7, 2025
VANCOUVER, British Columbia, April 07, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to report that it will be …
Senti Bio Joins Webull Corporate Connect Service Platform
GlobeNewswire
·
April 7, 2025
Company advancing off-the-shelf CAR-NK cell therapy programs for oncology indications with lead candidate, SENTI-202, in clinical development for the treatment of acute myeloid leukemia (AML) Connect with the Company on Webull here SOUTH SAN FRANCISCO, …
Noom appoints Dr. Jeffrey Egler as Chief Medical Officer to Lead Innovation in Healthy Aging and Longevity
GlobeNewswire
·
April 7, 2025
Dr. Egler brings extensive experience in functional medicine leadership to Noom as it expands its services to meet consumer health demands across a wider range of medical issues NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Noom, the leading digital …
Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma
GlobeNewswire
·
April 7, 2025
Designations Follow Recent Investigational New Drug (IND) Application Clearance for the RESOLUTION Basket Study of ALLO-329 in Rheumatology Dual CD19/CD70 CAR T Specifically Designed to Enhance Therapeutic Benefit, Expanding Treatment Potential Across a …
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
GlobeNewswire
·
April 7, 2025
Conduit expands its partnership with Sarborg to apply advanced machine learning-driven analysis on clinical data from its AstraZeneca-acquired assets, aiming to uncover new insights and optimize development pathways. NAPLES, Fla. and CAMBRIDGE, United …
NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)
GlobeNewswire
·
April 7, 2025
Moderate Alzheimer’s disease (AD) patients in the trial received the highest dose of troculeucel to date at 6 billion cells per treatment. After 12 months of treatment, both patients who completed 17 doses improved from moderate to mild AD within just 3 …